212 related articles for article (PubMed ID: 6288292)
1. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
Blazar B; Patarroyo M; Klein E; Klein G
J Exp Med; 1980 Mar; 151(3):614-27. PubMed ID: 6244358
[TBL] [Abstract][Full Text] [Related]
3. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.
Blazar BA; Fitzgerald J; Sutton L; Strome M
Clin Exp Immunol; 1983 Oct; 54(1):31-8. PubMed ID: 6311470
[TBL] [Abstract][Full Text] [Related]
6. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction.
Patarroyo M; Blazar B; Pearson G; Klein E; Klein G
Int J Cancer; 1980 Sep; 26(3):365-71. PubMed ID: 6270007
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
Aya T
Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
[TBL] [Abstract][Full Text] [Related]
8. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
Aya T; Mizuno F; Osato T
J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
Khyatti M; Patel PC; Stefanescu I; Menezes J
J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
[TBL] [Abstract][Full Text] [Related]
10. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
Williams LR; Quinn LL; Rowe M; Zuo J
J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent autologous lymphocyte cytotoxicity against cells freshly transformed by Epstein-Barr virus.
Aya T; Matsuo T; Takada K; Osato T; Mizuno F
IARC Sci Publ (1971); 1978; (24 Pt 2):711-9. PubMed ID: 221393
[TBL] [Abstract][Full Text] [Related]
12. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
Takaki K; Harada M; Sairenji T; Hinuma Y
J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
[TBL] [Abstract][Full Text] [Related]
13. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.
Tanner JE; Wei MX; Alfieri C; Ahmad A; Taylor P; Ooka T; Menezes J
J Infect Dis; 1997 Jan; 175(1):38-46. PubMed ID: 8985194
[TBL] [Abstract][Full Text] [Related]
14. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
Kurakata S; Ramos OF; Klein G; Klein E
Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
[TBL] [Abstract][Full Text] [Related]
15. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
Bradley TP; Bonavida B
Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
[TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
Jondal M
Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
Jondal M
Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
[TBL] [Abstract][Full Text] [Related]
19. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
[TBL] [Abstract][Full Text] [Related]
20. Interferon and natural killing of human lymphoma cell lines after induction of the Epstein Barr viral cycle by superinfection.
Blazar BA; Strome M; Schooley R
J Immunol; 1984 Feb; 132(2):816-20. PubMed ID: 6197476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
